The capture antibody first provides the binding site for the target molecule in the biological sample. A labeled detection antibody then binds the captured target, creating an immune complex associated with the bead. Fluorescent or enzymatic activity from that label produces the assay signal, allowing the presence or measured amount of the target to be assessed.
Different bead populations can carry different capture antibodies, so each population is associated with a particular analyte. When combined in one sample, they support simultaneous analysis of several proteins, hormones, pathogens, or other targets. This multiplex arrangement broadens the information obtained from a single assay while reducing the need to analyze each analyte separately.
The detection format depends on the label attached to the detection antibody. Fluorescent labels produce an optical signal, whereas enzymatic labels generate a measurable response through enzyme activity. Both formats connect detection-antibody binding to an analytical readout, enabling the assay to identify and measure target molecules in biological samples.
A typical workflow begins with antibody-coated beads contacting the biological sample, allowing target molecules to bind to the capture antibodies. A labeled detection antibody is then introduced so it can form an immune complex with the captured target. The resulting fluorescent or enzymatic signal is measured to determine the assay outcome for the selected analyte or analytes.
Researchers may select this approach when they need sensitive, high-throughput measurement of multiple biological targets or when sample and reagent quantities are limited. Its supported targets include proteins, hormones, pathogens, and other molecules. These features make the method useful for immunology studies, biomarker profiling, disease diagnostics, and drug development research.
In biology, the method links antibody specificity with multiplex measurement of molecules relevant to disease and biological responses. Researchers can apply it to immunology investigations, evaluate biomarker profiles, support disease diagnostic studies, or examine targets during drug development. Its ability to analyze several analytes while reducing sample and reagent requirements supports efficient experimental workflows.